Skip to main content
Livermore
Livermore
US stocksTW
ZHEN

Grifols SA

GIFLF
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0001438569

No open-market purchases or sales by Grifols SA insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Other share classesGRFSGIFOFGIKLY

Currency
EUR
Source
SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
Updated
Oct 14, 2026, 1:13 AM ET

Amounts are in EUR, the currency Grifols SA reports in. Lines marked ≈ US$ convert key figures to US dollars.

Income statement

Each column is one fiscal year, newest first.

Income statement of Grifols SA, annual
Line itemFY2024FY2023FY2022FY2021FY2020
Period endDec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020
Filing20-F20-F20-F20-F20-F
Reported–––––
RevenueEUR 7.21B≈ US$7.80BEUR 6.59B≈ US$7.13BEUR 6.06B≈ US$6.39BEUR 4.93B≈ US$5.84BEUR 5.34B≈ US$6.09B
Cost of revenueEUR 4.42BEUR 4.10BEUR 3.83BEUR 2.97BEUR 3.08B
Gross profitEUR 2.79BEUR 2.49BEUR 2.23BEUR 1.96BEUR 2.26B
Operating expensesEUR 1.64BEUR 1.76BEUR 1.55BEUR 1.42BEUR 1.28B
Research and developmentEUR 384.0MEUR 395.3MEUR 361.1MEUR 354.9MEUR 294.2M
Selling, general and administrativeEUR 1.26BEUR 1.37BEUR 1.19BEUR 1.06BEUR 985.6M
Operating incomeEUR 1.19BEUR 799.4MEUR 805.7MEUR 595.1MEUR 996.1M
Interest expenseEUR 714.8MEUR 596.9MEUR 496.5MEUR 278.0MEUR 249.6M
Income taxEUR 231.2MEUR 43.3MEUR 90.1MEUR 85.1MEUR 169.6M
Net incomeEUR 212.8M≈ US$230.3MEUR 180.7M≈ US$195.4MEUR 271.1M≈ US$285.6MEUR 265.3M≈ US$313.9MEUR 709.0M≈ US$809.0M
EPS, basicEUR 0.23EUR 0.09EUR 0.31EUR 0.28EUR 0.90
EPS, dilutedEUR 0.23EUR 0.09EUR 0.31EUR 0.28EUR 0.90
Weighted shares, basic679.7M679.8M679.8M681.6M685.5M
Weighted shares, diluted679.9M677.1M679.3M681.4M685.1M
Margins and growth
Gross margin38.7%37.8%36.8%39.8%42.2%
Operating margin16.5%12.1%13.3%12.1%18.7%
Net margin3.0%2.7%4.5%5.4%13.3%
Revenue growth, year over year+9.4%+8.7%+22.9%−7.6%+4.7%
Net income growth, year over year+17.8%−33.4%+2.2%−62.6%+9.3%

Balance sheet

Each column is one fiscal year, newest first.

Balance sheet of Grifols SA, annual
Line itemFY2024FY2023FY2022FY2021FY2020
Period endDec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020
Filing20-F20-F20-F20-F20-F
Reported–––––
Cash and equivalentsEUR 979.8MEUR 529.6MEUR 548.0MEUR 655.5MEUR 579.6M
Short-term investmentsEUR 237.5MEUR 116.6MEUR 31.0MEUR 2.03BEUR 11.1M
Accounts receivableEUR 705.5MEUR 645.1MEUR 608.7MEUR 432.2MEUR 383.2M
InventoryEUR 3.56BEUR 3.46BEUR 3.20BEUR 2.26BEUR 2.00B
Total current assetsEUR 5.73BEUR 6.45BEUR 4.65BEUR 5.51BEUR 3.16B
Property, plant and equipmentEUR 3.34BEUR 3.25BEUR 3.27BEUR 2.55BEUR 2.32B
GoodwillEUR 7.40BEUR 6.80BEUR 7.01BEUR 6.23BEUR 5.33B
Intangible assetsEUR 2.93BEUR 2.83BEUR 2.95BEUR 1.64BEUR 1.56B
Total assetsEUR 21.4B≈ US$22.2BEUR 21.4B≈ US$23.7BEUR 21.5B≈ US$23.0BEUR 19.2B≈ US$21.8BEUR 15.3B≈ US$18.7B
Accounts payableEUR 1.12BEUR 960.8MEUR 862.3MEUR 785.3MEUR 746.2M
Total current liabilitiesEUR 2.16BEUR 2.32BEUR 1.96BEUR 3.47BEUR 1.34B
Long-term debtEUR 2.34BEUR 3.65BEUR 3.59BEUR 3.58BEUR 3.30B
Total liabilitiesEUR 12.8BEUR 13.5BEUR 13.1BEUR 11.9BEUR 8.55B
Shareholders' equityEUR 8.61BEUR 7.97BEUR 8.46BEUR 7.32BEUR 6.72B

Cash flow statement

Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.

Cash flow statement of Grifols SA, annual
Line itemFY2024FY2023FY2022FY2021FY2020
Period endDec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020
Filing20-F20-F20-F20-F20-F
Reported–––––
Operating cash flowEUR 902.2M≈ US$976.1MEUR 208.3M≈ US$225.3MEUR -10.9M≈ US-$11.4MEUR 597.0M≈ US$706.2MEUR 1.11B≈ US$1.27B
Capital expendituresEUR 232.5MEUR 209.5MEUR 266.5MEUR 247.4MEUR 280.2M
Free cash flowEUR 669.6M≈ US$724.5MEUR -1.25M≈ US-$1.36MEUR -277.4M≈ US-$292.2MEUR 349.6M≈ US$413.6MEUR 830.2M≈ US$947.3M
Depreciation and amortizationEUR 437.9MEUR 441.9MEUR 407.9MEUR 359.8MEUR 321.5M
Dividends paidEUR 962.0KEUR 0EUR 592.0KEUR 258.9M–
Share buybacks–EUR 0EUR 3.46MEUR 125.7M–
Investing cash flowEUR 886.7MEUR -397.6MEUR -1.98BEUR -854.1MEUR -858.1M
Financing cash flowEUR -1.36BEUR 186.0MEUR -173.5MEUR 2.30BEUR -354.4M
Net change in cashEUR 450.2MEUR -18.4MEUR -2.13BEUR 2.10BEUR -162.3M

Shares outstanding

Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.

Grifols SA reports no single share count on its 10-K and 10-Q covers. Companies with several share classes report one count per class, which this data doesn't include.

Notes and known gaps

How these numbers are put together, and what they can't tell you.

  • Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
  • Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
  • ≈ US$ figures convert EUR at FRED H.10 exchange rates (Federal Reserve): the average rate over the period for income and cash flow, and the rate on the period-end date, or the last business day before it, for the balance sheet.

Known gaps

  • Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
  • EPS and share counts are as reported at the time, not adjusted for later stock splits.
  • For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
  • For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
  • Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
  • Depreciation and amortization is missing for some companies that report it under their own XBRL tags.